Literature DB >> 12810849

HOPE fixation of cytospin preparations of human cells for in situ hybridization and immunocytochemistry.

Oliver Umland1, Artur J Ulmer, Ekkehard Vollmer, Torsten Goldmann.   

Abstract

In primary or cultured cells, in situ hybridization (ISH) or immunocytochemistry (ICC) is often performed on tissue that has been fixed by paraformaldehyde or Carnoy's. Recently we reported an optimized HOPE (HEPES-glutamic acid buffer-mediated organic solvent protection effect) fixation protocol for ISH targeting mRNA in lung tissues. We have now examined whether HOPE fixation could also be used on in vitro cultured cells for targeting mRNA by ISH or proteins by ICC on cytospin preparations. Using the myeloid stem cell line KG-1a as a model system, we showed that HOPE fixation can be applied for ISH and ICC on cultured cells. HOPE can be used with cells and tissues and with a broad spectrum of immunohistocytochemical and molecular techniques.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12810849     DOI: 10.1177/002215540305100714

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  9 in total

1.  Proteomics out of the archive: Two-dimensional electrophoresis and mass spectrometry using HOPE-fixed, paraffin-embedded tissues.

Authors:  Daniel Kähler; Christian Alexander; Holger Schultz; Mahdi Abdullah; Detlev Branscheid; Buko Lindner; Peter Zabel; Ekkehard Vollmer; Torsten Goldmann
Journal:  J Histochem Cytochem       Date:  2009-12-07       Impact factor: 2.479

2.  Assessment of HOPE fixation in vitrectomy specimens in patients with chronic bilateral uveitis (masquerade syndrome).

Authors:  Sarah E Coupland; Alexandra Perez-Canto; Michael Hummel; Harald Stein; Heinrich Heimann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-05-21       Impact factor: 3.117

Review 3.  Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features.

Authors:  Sarah E Coupland; Heinrich Heimann; Nikolaos E Bechrakis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-10-29       Impact factor: 3.117

4.  HOPE-BAL: improved molecular diagnostics by application of a novel technique for fixation and paraffin embedding.

Authors:  Sebastian Marwitz; Mahdi Abdullah; Christina Vock; Jay S Fine; Sudha Visvanathan; Karoline I Gaede; Hans-Peter Hauber; Peter Zabel; Torsten Goldmann
Journal:  J Histochem Cytochem       Date:  2011-03-23       Impact factor: 2.479

5.  The HOPE fixation technique--a promising alternative to common prostate cancer biobanking approaches.

Authors:  Martin Braun; Roopika Menon; Pavel Nikolov; Robert Kirsten; Karen Petersen; David Schilling; Christina Schott; Sibylle Gündisch; Falko Fend; Karl-Friedrich Becker; Sven Perner
Journal:  BMC Cancer       Date:  2011-12-07       Impact factor: 4.430

6.  Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients.

Authors:  Daniel Droemann; Torsten Goldmann; Thorsten Tiedje; Peter Zabel; Klaus Dalhoff; Bernhard Schaaf
Journal:  Respir Res       Date:  2005-07-08

7.  Enhanced molecular analyses by combination of the HOPE-technique and laser microdissection.

Authors:  Torsten Goldmann; Renate Burgemeister; Ulrich Sauer; Siegfried Loeschke; Dagmar Silvia Lang; Detlev Branscheid; Peter Zabel; Ekkehard Vollmer
Journal:  Diagn Pathol       Date:  2006-03-31       Impact factor: 2.644

8.  Human lung cancer cells express functionally active Toll-like receptor 9.

Authors:  Daniel Droemann; Dirk Albrecht; Johannes Gerdes; Artur J Ulmer; Detlev Branscheid; Ekkehard Vollmer; Klaus Dalhoff; Peter Zabel; Torsten Goldmann
Journal:  Respir Res       Date:  2005-01-04

9.  A novel human ex vivo model for the analysis of molecular events during lung cancer chemotherapy.

Authors:  Dagmar S Lang; Daniel Droemann; Holger Schultz; Detlev Branscheid; Christian Martin; Anne R Ressmeyer; Peter Zabel; Ekkehard Vollmer; Torsten Goldmann
Journal:  Respir Res       Date:  2007-06-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.